MOBAN (molindone hydrochloride) · ENDO PHARMS
MOBAN is FDA-approved to treat 1 condition (same as MOLINDONE HYDROCHLORIDE).
Details
- Status
- Discontinued
- First Approved
- 1974-01-18
- Routes
- ORAL
- Dosage Forms
- CONCENTRATE, TABLET, CAPSULE
MOBAN Approval History
What MOBAN Treats
1 indicationsMOBAN is approved for 1 conditions since its original approval in 1974. These indications span multiple therapeutic areas including oncology, immunology, and more.
Same approved indications as MOLINDONE HYDROCHLORIDE (same active ingredient).
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MOBAN FDA Label Details
Indications & Usage
FDA Label (PDF)MOBAN is FDA-approved to treat 1 condition — same approved indications as MOLINDONE HYDROCHLORIDE.
Track MOBAN with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.